| Literature DB >> 25654670 |
Rebecca M Flueckiger1, Birgit Nikolay2, Huub C Gelderblom3, Jennifer L Smith2, Danny Haddad4, Wesley Tack5, Guy Hendrickx5, David Addiss6, Jorge Cano2, Danny R Hatcher7, Adrian Hopkins8, Rachel L Pullan2, Alex Pavluck9, Eric Ottesen10, Simon J Brooker2.
Abstract
Entities:
Year: 2015 PMID: 25654670 PMCID: PMC4318578 DOI: 10.1371/journal.pntd.0003400
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Currently available resources on the geographical distribution of NTDs.
|
|
|
|
|
|
|---|---|---|---|---|
| WHO preventive chemotherapy (PCT) databank | LF, STH, Sch, Tr | Country PCT data as officially reported to WHO. | Static country profiles including estimates of populations at risk, population requiring PCT, and program coverage. Country level tabular summaries are downloadable. Interactive LF mapping by country. |
|
| African Programme for Onchocerciasis Control (APOC) | Oncho, Loa loa | Field surveys using REMO or RAPLOA. | Static, downloadable country level maps of onchocerciasis and loa loa distribution, identifying areas requiring community-directed treatment with ivermectin. |
|
| Global Atlas of Helminth Infection [ | STH, Sch, LF | Structured searches of published and unpublished sources. | Static, downloadable country maps of survey data, predictive prevalence, and districts requiring MDA. Data available to download for selected countries and progress ongoing. |
|
| Global Atlas of Trachoma [ | Tr | Structured searches of literature and unpublished data from program managers. | Static, downloadable country level maps of the distribution of active trachoma in children under one to nine years and trichiasis in adults ≥ 15 years. |
|
| International Coalition for Trachoma Control | Tr | SAFE activities as reported by NGOs. | Static, downloadable country level maps of implementation of SAFE components. |
|
| Global NTD database [ | STH, Sch | Structured searches of published and unpublished sources. | Tabular form, including information on location, year, ages, and prevalence. No mapping platform currently available. |
|
1LF = lymphatic filariasis, STH = soil-transmitted helminths; Sch = schistosomiasis; Oncho = onchocerciasis; Tr = trachoma; SAFE = surgery, antibiotics, facial cleanliness, and environmental improvement, NGO = nongovernmental organization, REMO = rapid epidemiological mapping of onchocerciasis, RAPLOA = rapid assessment procedure for Loa loa.
The five main NTDs and the drugs and strategies used to target them programmatically.
| Disease | Drug(s) | Strategy | Target |
|---|---|---|---|
|
| albendazole/ivermectin or albendazole/DEC | MDA | Global elimination by 2020 [ |
|
| ivermectin | MDA + vector control [ | Regional and country elimination by 2025 [ |
|
| praziquantel | MDA + clean water and adequate sanitation, hygiene education, snail control [ | Control morbidity by 2020 and elimination by 2025 [ |
|
| albendazole or mebendazole | MDA + clean water, sanitary latrines, hygiene education [ | Control |
|
| azithromycin | MDA + surgery to correct trichiasis + facial cleanliness + environmental improvement (SAFE) [ | Global elimination of blinding trachoma by 2020 [ |
iPrevalence of infection with Wuchereria bancrofti, Brugia malayi, or Brugia timori less than target thresholds in all endemic areas in all countriessite. Interrupt transmission and reduce the at-risk population to zero [13]
iiPrevalence of infection with Onchocerca volvulus less than target threshold in children less than ten years old, and prevalence of infective larvae in Simulium flies less than target threshold. Verified after a minimum period of 3–5 consecutive years of adequate postintervention surveillance
iiiControl is the elimination of infections of moderate and high intensity (Ascarsis lumbricoides >5,000 epg, Trichuris trichiura >1,000 epg, Necator americanus or Ancylostoma duodenale >2,000 epg) [19]
ivIncidence of less than one case of trichiasis per 1,000 population and less than 5% of children between the ages of one and nine years old having active disease (TF) in each endemic country. Verified after a minimum period of three consecutive years of adequate postintervention surveillance
*MDA—Mass Drug Administration—can target entire at-risk communities (e.g., for LF or oncho) or segments of the population (e.g., school-age children for STH)
Fig 1Ratings of functionality of mapping tool functions, based on an end-user survey of 105 participants from 45 countries, 2012.
Fig 2Ratings of applications of a mapping tool, based on an end-user survey of 105 participants from 45 countries, 2012.
NTDmap.org minimum criteria.
|
|
|
|---|---|
| Epidemiological uses |
Determining current distribution of each NTD Identifying coendemicity of different NTDs Identifying areas without survey data |
| Programmatic uses |
Assessing intervention coverage Identifying intervention gaps Forecasting future intervention needs Supporting evaluation and surveillance efforts |
| Data to include |
Endemicity status: known to be endemic above threshold for MDA; known to be nonendemic above threshold for MDA Treatment data: whether MDA is ongoing (yes/no); whether adequate MDA has been achieved, based on NTD-specific threshold (yes/no) WASH information |
| Administration |
Information will be provided from the NTD-specific atlases on a quarterly basis Information will be pulled from existing databases, leaving quality control in the hands of the original data managers |
Fig 3Linking existing databases through a mapping server allows for geographic display of tabular data.
Fig 4Practical use of NTDmap.org, trachoma, and STH in Ethiopia.